Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
41.11
+0.90 (2.25%)
At close: Jun 6, 2025, 4:00 PM
41.09
-0.01 (-0.04%)
After-hours: Jun 6, 2025, 5:59 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $7.65 billion as of June 6, 2025. Its market cap has increased by 16.97% in one year.
Market Cap
7.65B
Enterprise Value
5.69B
1-Year Change
16.97%
Ranking
Category
Stock Price
$41.11
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $7.65B, an increase of 365.42%. That is a compound annual growth rate of 33.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 7.65B | -5.31% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.67B |
| Johnson & Johnson | 372.56B |
| AbbVie | 334.79B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 271.23B |
| Abbott Laboratories | 232.89B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |